financial estimates
HTG Molecular Preliminary Q1 Revenues Fall 56 Percent
For the three months ended March 31, the firm said that preliminary revenues for Q1 are expected to be $1.4 million compared with $3.2 million a year ago.
360Dx Index Declines 2 Percent in March, Continuing Downward Slope
Of the 31 companies in the index, 11 firms saw their stock prices increase, while 20 saw their share prices decline.
Exagen Q4 2020 Revenues Up 24 Percent, Full Year Revenues Grow 4 Percent
The company's fourth quarter revenues rose to $12.7 million, while full year revenues rose to $42 million.
LabCorp Q4 Revenues Rise 52 Percent
Revenues were $4.49 billion, up from $2.95 billion in the same quarter last year and beating analysts' average estimate of $3.95 billion.
Meridian Bioscience Fiscal Q1 Revenues Rise 96 Percent
The firm's life science revenues increased nearly fivefold, while diagnostics revenues declined 13 percent year over year.
Feb 27, 2019
Opko Health Q4 Revenues Rise 38 Percent
Feb 20, 2019
Invitae Q4 2018 Revenues Grow 78 Percent
Feb 5, 2019
Myriad Genetics Q2 Revenues Increase 15 Percent
Dec 13, 2018
Danaher Initiates 2019 EPS Outlook
Feb 5, 2018